- Home
- SYNX vs NRXS Comparison
SYNX vs NRXS Comparison
Compare SYNX & NRXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SYNX
- NRXS
- Stock Information
- Founded
- SYNX 2005
- NRXS 2011
- Country
- SYNX Israel
- NRXS United States
- Employees
- SYNX N/A
- NRXS N/A
- Industry
- SYNX
- NRXS
- Sector
- SYNX
- NRXS
- Exchange
- SYNX Nasdaq
- NRXS Nasdaq
- Market Cap
- SYNX 18.5M
- NRXS 17.3M
- IPO Year
- SYNX 2024
- NRXS 2023
- Fundamental
- Price
- SYNX $4.46
- NRXS $2.85
- Analyst Decision
- SYNX
- NRXS
- Analyst Count
- SYNX 0
- NRXS 0
- Target Price
- SYNX N/A
- NRXS N/A
- AVG Volume (30 Days)
- SYNX 72.7K
- NRXS 30.7K
- Earning Date
- SYNX 10-02-2024
- NRXS 11-12-2024
- Dividend Yield
- SYNX N/A
- NRXS N/A
- EPS Growth
- SYNX N/A
- NRXS N/A
- EPS
- SYNX N/A
- NRXS N/A
- Revenue
- SYNX $9,893,000.00
- NRXS $2,456,219.00
- Revenue This Year
- SYNX $52.34
- NRXS $383.16
- Revenue Next Year
- SYNX N/A
- NRXS N/A
- P/E Ratio
- SYNX N/A
- NRXS N/A
- Revenue Growth
- SYNX 18.05
- NRXS N/A
- 52 Week Low
- SYNX $2.10
- NRXS $2.00
- 52 Week High
- SYNX $6.49
- NRXS $3.89
- Technical
- Relative Strength Index (RSI)
- SYNX 63.44
- NRXS 61.76
- Support Level
- SYNX $3.80
- NRXS $2.48
- Resistance Level
- SYNX $4.69
- NRXS $2.83
- Average True Range (ATR)
- SYNX 0.60
- NRXS 0.26
- MACD
- SYNX 0.00
- NRXS 0.05
- Stochastic Oscillator
- SYNX 36.36
- NRXS 72.86
About SYNX Silynxcom Ltd.
Silynxcom Ltd is engaged in developing, manufacturing, marketing and selling ruggedized Personal Headset Devices as well as other communications accessories, all of which have been battlefield-tested and combat-proven. It specializes in developing the In-Ear Headset device, a subsegment of the Personal Headset Device market. The In-Ear Headset device is used in both in training and operations by the military, law enforcement, and disaster recovery industry professionals. It also develops, market and sell push-to-talk devices, communication controllers, and communication device cables and connectors.
About NRXS Neuraxis Inc.
Neuraxis Inc is a growth stage company is engaged in developing neuromodulation therapies to address chronic and debilitating conditions in children. The company is dedicated to advancing the science with its' proprietary Percutaneous Electrical Nerve Field Stimulation (PENFS) technology. The company focuses on targeted therapies for the pediatric and adolescent population suffering from disorders of gut-brain interaction (DGBIs).